SCHEMBL4990941

SCHEMBL4990941

CC(C)(C)OC(=O)N1CCC(n2ccc3ccc(Cl)cc32)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 6/20 0.47
MAPT P10636 2/20 0.47
KDM4E B2RXH2 1/20 0.47
THRB P10828 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
HCAR1 Q9BXC0 1/20 0.45
SCD O00767 1/20 0.43
USP2 O75604 1/20 0.43
HPGD P15428 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GPR119 Q8TDV5 2/20 0.43
NR3C1 P04150 1/20 0.43
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5253861 0.91 STS (0.47) STSMAPTKDM4ETHRBMEN1
SCHEMBL5254890 0.87 GPR119 (0.51) MAPTKDM4ETHRBMEN1KMT2A
SCHEMBL25339026 0.86 USP30 (0.52) MAPTKDM4ETHRBHCAR1GPR119
SCHEMBL12459067 0.86 NR1H2 (0.47) MAPTKDM4ETHRBHCAR1GPR119
SCHEMBL13537239 0.84 HCAR1 (0.43) MAPTKDM4ETHRBHCAR1GPR119
SCHEMBL22802021 0.84 HCAR1 (0.47) MAPTKDM4ETHRBMEN1KMT2A
SCHEMBL3159082 0.83 GPR119 (0.52) STSMAPTKDM4ETHRBHCAR1
SCHEMBL3354815 0.83 MAPT (0.52) MAPTKDM4ETHRBHCAR1GPR119
SCHEMBL5255201 0.81 GPR119 (0.51) MAPTKDM4ETHRBMEN1KMT2A
SCHEMBL12471639 0.80 HCAR1 (0.43) MAPTKDM4ETHRBHCAR1GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7405305-B2 Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors ELI LILLY AND COMPANY (US) 2008-07-29 US disclosed
EP-1487822-B1 PYRROLE-2,5-DIONE DERIVATIVES AND THEIR USE AS GSK-3 INHIBITORS LILLY CO ELI (US) 2007-08-01 EP disclosed
US-20050288321-A1 Kinase inhibitors ELI LILLY AND COMPANY 2005-12-29 US disclosed
CN-1639152-A Pyrrole-2, 5-dione derivatives and their use as GSK-3 inhibitors LILLY CO ELI (US) 2005-07-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288321-A1 Kinase inhibitors ABL1, MAP3K20, MAP3K19 STS 2713/4885MAPT 2735/4885KDM4E 739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.